openPR Logo

Press Releases from TMR=Antibody Drug Conjugates (1 total)

Antibody Drug Conjugates Market Driven by Extensive Research and Development Act …

Antibody drug conjugates are monoclonal antibodies that are attached with biologically active drugs. The combination of cytotoxic drugs and the targeting capacity of molecular antibodies allows antibody drug conjugates to perform targeted therapy to treat cancer patients. This allows a sensitive discrimination between cancerous tissues and healthy tissues. As the global antibody drug conjugates market is in an infancy stage, only three antibody drug conjugates have received market approval from

Go To Page:   1 2 3 4 5 6 7 8 9 10